BIOTRONIK has launched the Pantera Lux balloon catheter that features a matrix of paclitaxel and biocompatible carrier. The device was designed for treating coronary lesions that have occluded post implantation of a stent. The treatment allows for reopening of the vessel without having to put another stent in.
From the announcement:
The BIOTRONIK drug eluting balloon (DEB) makes use of paclitaxel as an antiproliferative treatment due to its rapid uptake and prolonged retention. The absorption properties of the drug are further enhanced with the addition of an excipient, called butyryl-tri-hexyl citrate (BTHC), which acts as an agent to keep the paclitaxel micro-crystalline, a form that shows even faster uptake by the vessel wall. BTHC is a safe and well characterized compound used in other blood-related medical devices.
The Pantera Lux balloon was designed with the underlying Pantera balloon technology as the delivery device.